ERA4Health 2027 – Nano and advanced technologies for diagnostic tools (NanoDiagNCD)
The ERA4Health 2027 NanoDiagNCD call supports transnational research consortia developing nano and advanced technology diagnostic tools to improve detection and clinical management of non-communicable diseases. This guide covers research areas consistent with the call, eligibility and readiness checks, what assessment panels typically value and how to plan for the 19 January 2027 deadline, with the call opening on 17 November 2026 and full proposals due on 9 June 2027.
The published deadline has passed. Check the official page in case it has been extended, or browse the open listings.
Key dates
- Application deadline
- 19 January 2027
- Details last checked
- 10 November 2026
About the call
- Funder
- ERA4Health Partnership
- Country
- International
- Scheme type
- Project grant
- Funding
- As stated in the call documents
- Eligibility
- Transnational research consortia developing nano and advanced technology diagnostic tools to improve detection and clinical management of non-communicable diseases; call opens 17 Nov 2026, full proposals due 9 Jun 2027.
- Scope
- Biomedical engineering and devices
Topics consistent with the call
- Nanomaterial-based biosensors for early detection of non-communicable diseases
- Point-of-care diagnostic devices for chronic disease management
- Advanced imaging and contrast agents for diagnosis
- Liquid biopsy and biomarker detection technologies
- Integration of diagnostic devices with digital health and data analysis
- Clinical validation of novel diagnostic tools
Based on the published scope; the official page sets out the full themes and requirements.
Is your work a fit? Check before you apply
- Confirm the project develops nano or advanced technology diagnostics for non-communicable diseases.
- Build a transnational consortium that meets the partnership’s eligibility rules.
- Check national funding rules for each partner in the official call documents.
- Plan the work towards clinical relevance, including validation where appropriate.
- Prepare a complete, institutionally approved application before 19 January 2027.
Why This Funding Call Matters
Non-communicable diseases such as cancer, cardiovascular disease and diabetes account for much of the burden on health systems, and earlier and more precise diagnosis can improve outcomes. Nanotechnology and other advanced technologies offer new ways to detect disease markers sensitively and at the point of care. Transnational funding allows consortia to combine engineering, clinical and industrial expertise needed to move diagnostic tools towards practical use.
Who Should Apply
Academic backgrounds
- Nanotechnology and materials science
- Biomedical engineering
- Clinical medicine
- Analytical chemistry
- Medical physics
Institutions and sectors
- Universities and research institutes
- University hospitals
- Medical device and diagnostics companies
- SMEs in nanotechnology
What Reviewers Typically Value
- A diagnostic approach that offers a clear advance over current methods.
- A consortium combining technical, clinical and translational expertise.
- A credible pathway towards clinical validation and use.
- Attention to regulatory, ethical and usability considerations.
Ideas You Could Develop
Your Plan to the Deadline
A suggested schedule working back from 19 January 2027. Adjust it to the stage your work has reached.
By 24 Nov 2026
Read the call documents; confirm eligibility, budget limits, assessment criteria and institutional requirements.
By 8 Dec 2026
Agree the research question, aims, team and partners; contact your research office.
By 22 Dec 2026
Draft the case for support, methods, impact and budget.
By 5 Jan 2027
Obtain internal review, letters of support and institutional sign-off.
By 14 Jan 2027
Final checks against the funder’s guidance and formatting rules.
By 19 Jan 2027
Submit through the funder’s system before the deadline.
What you gain
- Funding for the research, team and resources it needs.
- Recognition from a competitive, peer-reviewed process.
- Reviewer feedback that strengthens future applications.
- A track record for larger grants and fellowships.
What happens after you apply
- Eligibility check: the funder confirms the application meets the call rules.
- Peer review: external reviewers assess the proposal against the published criteria.
- Panel: a committee ranks proposals; some schemes include an interview.
- Decision: outcomes are released on the funder’s timetable.
- Award: successful applicants agree terms and reporting requirements before starting.
What the Funder Are Looking For
ERA4Health is looking for transnational consortia developing nano and advanced technology diagnostic tools that improve detection and clinical management of non-communicable diseases. Strong proposals typically combine technical innovation with clinical relevance, a capable multidisciplinary consortium and a realistic plan towards validation. National eligibility, budgets and the two-stage process should be confirmed in the official call documents published by ERA4Health and its partner agencies.
Expert help
How Pubrica Can Help
Pubrica’s subject specialists can help you prepare a competitive proposal, planned back from the deadline. You remain the author of your work.
FAQs
Questions Researchers Ask
The next published deadline is 19 January 2027. Dates can change, so confirm them on the official page before you plan your work.
The call focuses on non-communicable diseases, so infectious disease diagnostics are unlikely to fit unless the call documents state otherwise. Check the scope in the official ERA4Health call text before forming a consortium.
Transnational research consortia developing nano and advanced technology diagnostic tools to improve detection and clinical management of non-communicable diseases; call opens 17 Nov 2026, full proposals due 9 Jun 2027. Confirm the full eligibility rules in the call documents.
Yes. Pubrica’s specialists can review, write, edit and format your proposal. You remain the author and the person responsible for the submission.
Sources
- ERA4Health Partnership. (2026). ERA4Health 2027 – Nano and advanced technologies for diagnostic tools (NanoDiagNCD). Retrieved 10 November 2026, from https://anr.fr/en/call-for-proposals-details/call/preannouncement-era4health-2027-nano-and-advanced-technologies-for-developing-diagnostic-tools-to-i/
How to cite this page
Pubrica Insights. (2026). ERA4Health 2027 – Nano and advanced technologies for diagnostic tools (NanoDiagNCD). Pubrica. https://pubrica.com/insights/calls-and-conferences/era4health-2027-nano-and-advanced-technologies-for-diagnostic-tools-na/
Pubrica Insights. “ERA4Health 2027 – Nano and advanced technologies for diagnostic tools (NanoDiagNCD).” Pubrica, 2026, https://pubrica.com/insights/calls-and-conferences/era4health-2027-nano-and-advanced-technologies-for-diagnostic-tools-na/.
Pubrica Insights (2026) ERA4Health 2027 – Nano and advanced technologies for diagnostic tools (NanoDiagNCD). Pubrica. Available at: https://pubrica.com/insights/calls-and-conferences/era4health-2027-nano-and-advanced-technologies-for-diagnostic-tools-na/ (Accessed: 10 November 2026).
Pubrica Insights. ERA4Health 2027 – Nano and advanced technologies for diagnostic tools (NanoDiagNCD) [Internet]. Pubrica; 2026 [cited 2026 Nov 10]. Available from: https://pubrica.com/insights/calls-and-conferences/era4health-2027-nano-and-advanced-technologies-for-diagnostic-tools-na/
Funding call